The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
International epidemiology of prostate cancer: Geographical distribution and secular trends
Abstract
This review outlines current international patterns in prostate cancer incidence and mortality rates and survival, including recent trends and a discussion of the possible impact of prostate‐specific antigen (PSA) testing on the observed data. Internationally, prostate cancer is the second most common cancer diagnosed among men (behind lung cancer), and is the sixth most common cause of cancer death among men. Prostate cancer is particularly prevalent in developed countries such as the United States and the Scandinavian countries, with about a six‐fold difference between high‐incidence and low‐incidence countries. Interpretation of trends in incidence and survival are complicated by the increasing impact of PSA testing, particularly in more developed countries. As Western influences become more pronounced in less developed countries, prostate cancer incidence rates in those countries are tending to increase, even though the prevalence of PSA testing is relatively low. Larger proportions of younger men are being diagnosed with prostate cancer and living longer following diagnosis of prostate cancer, which has many implications for health systems. Decreasing mortality rates are becoming widespread among more developed countries, although it is not clear whether this is due to earlier diagnosis (PSA testing), improved treatment, or some combination of these or other factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196
Cancer Incidence in Five Continents
(1970) · Springer eBooks · doi:10.1007/978-3-642-85851-2 · Cited by 8,501
Jemal, A., Tiwari, R. C., Murray, T., Ghafoor, A., Samuels, A., Ward, E., Feuer, E. J., & Thun, M. J. (2004) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.54.1.8 · Cited by 3,984
Kamangar, F., Dores, G. M., & Anderson, W. F. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.2308 · Cited by 3,434
Recent cancer survival in Europe: a 2000–02 period analysis of EUROCARE-4 data
Verdecchia, A., Francisci, S., Brenner, H., Gatta, G., Micheli, A., Mangone, L., & Kunkler, I. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70246-2 · Cited by 1,285
Grönberg, H. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12713-4 · Cited by 1,219
Longitudinal Evaluation of Prostate-Specific Antigen Levels in Men With and Without Prostate Disease
Carter, H. B. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03480160073037 · Cited by 1,096
Draisma, G., Boer, R., Otto, S. J., van der Cruijsen, I. W., Damhuis, R. A. M., Schroder, F. H., & de Koning, H. J. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.12.868 · Cited by 1,071
Edwards, B. K., Brown, M. L., Wingo, P. A., Howe, H. L., Ward, E., Ries, L. A. G., Schrag, D., Jamison, P. M., Jemal, A., Wu, X. C., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji289 · Cited by 952
Etzioni, R. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.13.981 · Cited by 949
International trends and patterns of prostate cancer incidence and mortality
Hsing, A. W., Tsao, L., & Devesa, S. S. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000101)85:1<60::aid-ijc11>3.0.co;2-b · Cited by 846
A Randomized Trial Comparing Radical Prostatectomy with Watchful Waiting in Early Prostate Cancer
Holmberg, L., Bill-Axelson, A., Helgesen, F., Salo, J. O., Folmerz, P., Häggman, M., Andersson, S.-O., Spångberg, A., Busch, C., Nordling, S., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012794 · Cited by 817
Swan, J., Breen, N., Coates, R. J., Rimer, B. K., & Lee, N. C. (2003) · Cancer · doi:10.1002/cncr.11208 · Cited by 767
The Frequency of Carcinoma and Intraepithelial Neoplasia of the Prostate in Young Male Patients
Sakr, W. A., Haas, G. P., Cassin, B. F., Pontes, J. E., & Crissman, J. D. (1993) · Journal of Urology · doi:10.1016/s0022-5347(17)35487-3 · Cited by 745
Natural History of Early, Localized Prostate Cancer
Johansson, J.-E. (2004) · JAMA · doi:10.1001/jama.291.22.2713 · Cited by 703
Hankey, B. F., Feuer, E. J., Clegg, L. X., Hayes, R. B., Legler, J. M., Prorok, P. C., Ries, L. A., Merrill, R. M., & Kaplan, R. S. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.12.1017 · Cited by 652
ANATOMIC RADICAL PROSTATECTOMY: EVOLUTION OF THE SURGICAL TECHNIQUE
WALSH, P. C. (1998) · Journal of Urology · doi:10.1016/s0022-5347(01)62202-x · Cited by 582
Shibuya, K., Mathers, C. D., Boschi-Pinto, C., Lopez, A. D., & Murray, C. J. (2002) · BMC Cancer · doi:10.1186/1471-2407-2-37 · Cited by 467
Sirovich, B. E., Schwartz, L. M., & Woloshin, S. (2003) · JAMA · doi:10.1001/jama.289.11.1414 · Cited by 369
Screening for Prostate Cancer: An Update of the Evidence for the U.S. Preventive Services Task Force
Harris, R., & Lohr, K. N. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-11-200212030-00014 · Cited by 348
Catalona, W. J., Southwick, P. C., Slawin, K. M., Partin, A. W., Brawer, M. K., Flanigan, R. C., Patel, A., Richie, J. P., Walsh, P. C., Scardino, P. T., et al. (2000) · Urology · doi:10.1016/s0090-4295(00)00637-3 · Cited by 335
Changing demography of prostate cancer in Asia
Sim, H. G., & Cheng, C. W. S. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2004.12.033 · Cited by 319
de Koning, H. J., Auvinen, A., Berenguer Sanchez, A., Calais da Silva, F., Ciatto, S., Denis, L., Gohagan, J. K., Hakama, M., Hugosson, J., Kranse, R., et al. (2002) · International Journal of Cancer · doi:10.1002/ijc.1588 · Cited by 285
The Epidemiology of Prostatic Cancer: Geographical Distribution and time-trends
Muir, C. S., Nectoux, J., & Staszewski, J. (1991) · Acta Oncologica · doi:10.3109/02841869109092336 · Cited by 255
Early prostate cancer: clinical decision-making
Jani, A. B., & Hellman, S. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12833-4 · Cited by 217
Lu-Yao, G., Albertsen, P. C., Stanford, J. L., Stukel, T. A., Walker-Corkery, E. S., & Barry, M. J. (2002) · BMJ · doi:10.1136/bmj.325.7367.740 · Cited by 216
Frankel, S., Smith, G. D., Donovan, J., & Neal, D. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12890-5 · Cited by 215
Causes of Death in Elderly Prostate Cancer Patients and in a Comparison Nonprostate Cancer Cohort
Newschaffer, C. J., Otani, K., McDonald, M. K., & Penberthy, L. T. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.8.613 · Cited by 214
Etzioni, R., Legler, J. M., Feuer, E. J., Merrill, R. M., Cronin, K. A., & Hankey, B. F. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.12.1033 · Cited by 213
Epidemiology and Pathophysiology of Prostate Cancer in African-American Men
Powell, I. J. (2007) · Journal of Urology · doi:10.1016/j.juro.2006.09.024 · Cited by 184
Trends in prostate cancer mortality among black men and white men in the United States
Chu, K. C., Tarone, R. E., & Freeman, H. P. (2003) · Cancer · doi:10.1002/cncr.11212 · Cited by 183
International trends in prostate-cancer mortality in the ?PSA era?
Oliver, S. E., May, M. T., & Gunnell, D. (2001) · International Journal of Cancer · doi:10.1002/ijc.1260 · Cited by 181
(2023) · New England Journal of Medicine · doi:10.1056/nejmc2305651 · Cited by 178
Legler, J. M., Feuer, E. J., Potosky, A. L., et al. (1998) · Cancer Causes & Control · doi:10.1023/a:1008805718310 · Cited by 152
Parker, C. C., Muston, D., Melia, J., Moss, S., & Dearnaley, D. P. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603105 · Cited by 142
Surgery, brachytherapy, and external-beam radiotherapy for early prostate cancer
Peschel, R. E., & Colberg, J. W. (2003) · The Lancet Oncology · doi:10.1016/s1470-2045(03)01035-0 · Cited by 137
Rising prostate cancer rates in South Korea
Park, S. K., Sakoda, L. C., Kang, D., Chokkalingam, A. P., Lee, E., Shin, H., Ahn, Y., Shin, M., Lee, C.-W., Lee, D., et al. (2006) · The Prostate · doi:10.1002/pros.20419 · Cited by 116
International Trends in Prostate-Cancer Mortality: The Decrease is Continuing and Spreading
Baade, P. D., Coory, M. D., & Aitken, J. F. (2004) · Cancer Causes & Control · doi:10.1023/b:caco.0000024212.66334.26 · Cited by 109
Self-citationMelia, J., Moss, S., Johns, L. E., & laboratories, C. I. T. P. (2004) · British Journal of Urology · doi:10.1111/j.1464-4096.2004.04832.x · Cited by 105
Albertsen, P. C., WALTERS, S., & Hanley, J. A. (2000) · The Journal of Urology · doi:10.1016/s0022-5347(05)67915-3 · Cited by 104
Why is the prostate cancer death rate declining in the united states?
Mettlin, C. J., & Murphy, G. P. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980115)82:2<249::aid-cncr1>3.0.co;2-m · Cited by 94
Konety, B. R., Bird, V. Y., Deorah, S., & Dahmoush, L. (2005) · The Journal of Urology · doi:10.1097/01.ju.0000177470.84735.55 · Cited by 91
Evidence to Support a Continued Stage Migration and Decrease in Prostate Cancer Specific Mortality
Galper, S. L., Chen, M., Catàlona, W. J., Roehl, K. A., Richie, J. P., & D'Amico, A. V. (2006) · The Journal of Urology · doi:10.1016/s0022-5347(05)00419-2 · Cited by 91
Brenner, H., & Arndt, V. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2005.11.148 · Cited by 88
Coldman, A. J., Phillips, N., & Pickles, T. (2003) · Europe PMC (PubMed Central) · Cited by 81
Surgery and the Reduction of Mortality from Prostate Cancer
Walsh, P. C. (2002) · New England Journal of Medicine · doi:10.1056/nejme020089 · Cited by 71
Miller, D. C., Zheng, S. L., Dunn, R. L., Sarma, A. V., Montie, J. E., Lange, E. M., Meyers, D. A., Xu, J., & Cooney, K. A. (2003) · PubMed · Cited by 68
Prostate cancer: to screen or not to screen?
Neal, D. E., & Donovan, J. (2000) · The Lancet Oncology · doi:10.1016/s1470-2045(00)00005-x · Cited by 67
Prostate brachytherapy has come of age: a review of the technique and results
Langley, S. E. M., & Laing, R. W. (2002) · British Journal of Urology · doi:10.1046/j.1464-4096.2001.01610.x · Cited by 64
Secular trends in prostate cancer mortality, incidence and treatment: England and Wales, 1975–2004
Hussain, S., Gunnell, D., Donovan, J., McPhail, S., Hamdy, F. C., Neal, D. E., Albertsen, P. C., Verne, J., Stephens, P. J., Trotter, C. L., et al. (2008) · British Journal of Urology · doi:10.1111/j.1464-410x.2007.07338.x · Cited by 62
Prostate cancer screening, changing age‐specific incidence trends and implications on familial risk
Hemminki, K., Rawal, R., & Bermejo, J. L. (2004) · International Journal of Cancer · doi:10.1002/ijc.20568 · Cited by 49
Recent trends in the use of radical prostatectomy in England: the epidemiology of diffusion
Oliver, S. E., Donovan, J., Peters, T. J., Frankel, S., Hamdy, F. C., & Neal, D. E. (2003) · British Journal of Urology · doi:10.1046/j.1464-410x.2003.04083.x · Cited by 49
Lifetime and Recent Prostate Specific Antigen (PSA) Screening of Men for Prostate Cancer in Canada
Beaulac, J., Fry, R. N., & Onysko, J. (2006) · Canadian Journal of Public Health · doi:10.1007/bf03405578 · Cited by 48
Evidence of prostate cancer screening in a UK region
Gavin, A., McCarron, P. A., Middleton, R., et al. (2004) · British Journal of Urology · doi:10.1111/j.1464-410x.2003.04716.x · Cited by 46
Varenhorst, E., Garmo, H., Holmberg, L., et al. (2005) · Scandinavian Journal of Urology and Nephrology · doi:10.1080/00365590510007793 · Cited by 45
The physical burden of prostate cancer
Penson, D. F., & Litwin, M. S. (2003) · Urologic Clinics of North America · doi:10.1016/s0094-0143(02)00187-8 · Cited by 41
Survey of the rate of PSA testing in general practice
Melia, J., & Moss, S. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1962 · Cited by 40
Albertsen, P. C. (2005) · Acta Oncologica · doi:10.1080/02841860410002815 · Cited by 33
Decreasing mortality rates for prostate cancer: possible role of hormonal therapy?
Damber, J. (2004) · British Journal of Urology · doi:10.1111/j.1464-410x.2003.04713.x · Cited by 25
Screening for Prostate Cancer: Current Status and Future Prospects
Sharifi, N., & Kramer, B. S. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.12.014 · Cited by 9
Cited by
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Global cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,850
Cancer statistics in China, 2015
Chen, W., Zheng, R., Baade, P. D., Zhang, S., Zeng, H., Bray, F., Jemal, A., Yu, X. Q., & He, J. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21338 · Cited by 17,038
Self-citationGlobal Cancer Incidence and Mortality Rates and Trends—An Update
Torre, L. A., Siegel, R. L., Ward, E. M., & Jemal, A. (2016) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0578 · Cited by 3,692
Global patterns of cancer incidence and mortality rates and trends
Jemal, A., Center, M. M., DeSantis, C., & Ward, E. M. (2010) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0437 · Cited by 2,778
Metadata
- Authors
- Baade, P. D., Youlden, D. R., & Krnjacki, L. J.
- Venue
- Molecular Nutrition & Food Research
- Publisher
- Wiley
- Published
- 2009-02
- Volume
- 53
- Issue
- 2
- Pages
- 171-184
- ISSN
- 1613-4125 (ISSN-L)
- 1613-4133
- OpenAlex
- W1971183831
- Cited by
- 444
- References
- 60
- FWCI
- 8.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.